Ab&B Bio-Tech Lists on HKEX Raising $55 Million in IPO

Marco Zingaro Asia & Pacific Legal Chronicle
Tagged:

Linklaters has advised Ab&B Bio-Tech CO., LTD. Ab&B Bio-Tech CO., LTD., a China-based vaccine development company, has completed its global offering and listing of H shares…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here